Literature DB >> 15282312

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

Akira Kobayashi1, Moon-Il Kang, Hiromi Okawa, Makiko Ohtsuji, Yukari Zenke, Tomoki Chiba, Kazuhiko Igarashi, Masayuki Yamamoto.   

Abstract

Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress. In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degradation through the proteasome system. We examined the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct association between Keap1 and Nrf2 is required for Nrf2 degradation. In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degradation, implying that these two domains act to recruit ubiquitin-proteasome factors. Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo. Keap1 associates with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex. These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase. To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, respectively, of the Cul3-based E3 ligase system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282312      PMCID: PMC479737          DOI: 10.1128/MCB.24.16.7130-7139.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

Review 1.  Regulatory mechanisms of cellular response to oxidative stress.

Authors:  K Itoh; T Ishii; N Wakabayashi; M Yamamoto
Journal:  Free Radic Res       Date:  1999-10

2.  Covalent modification of all members of human cullin family proteins by NEDD8.

Authors:  T Hori; F Osaka; T Chiba; C Miyamoto; K Okabayashi; N Shimbara; S Kato; K Tanaka
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site.

Authors:  T Oyake; K Itoh; H Motohashi; N Hayashi; H Hoshino; M Nishizawa; M Yamamoto; K Igarashi
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.

Authors:  J D Singer; M Gurian-West; B Clurman; J M Roberts
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

6.  Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for gamma-glutamylcysteine synthetase.

Authors:  K R Sekhar; S R Soltaninassab; M J Borrelli; Z Q Xu; M J Meredith; F E Domann; M L Freeman
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

7.  The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.

Authors:  M A Wall; D E Coleman; E Lee; J A Iñiguez-Lluhi; B A Posner; A G Gilman; S R Sprang
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

8.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

9.  Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.

Authors:  Nobunao Wakabayashi; Albena T Dinkova-Kostova; W David Holtzclaw; Moon-Il Kang; Akira Kobayashi; Masayuki Yamamoto; Thomas W Kensler; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

10.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.

Authors:  Anna-Liisa Levonen; Aimee Landar; Anup Ramachandran; Erin K Ceaser; Dale A Dickinson; Giuseppe Zanoni; Jason D Morrow; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more
  803 in total

1.  p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.

Authors:  Ashish Jain; Trond Lamark; Eva Sjøttem; Kenneth Bowitz Larsen; Jane Atesoh Awuh; Aud Øvervatn; Michael McMahon; John D Hayes; Terje Johansen
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  High levels of Nrf2 determine chemoresistance in type II endometrial cancer.

Authors:  Tao Jiang; Ning Chen; Fei Zhao; Xiao-Jun Wang; Beihua Kong; Wenxin Zheng; Donna D Zhang
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 3.  Modulation of oxidative stress and mitochondrial function by the ketogenic diet.

Authors:  Julie Milder; Manisha Patel
Journal:  Epilepsy Res       Date:  2011-11-09       Impact factor: 3.045

4.  Marine Natural Product Honaucin A Attenuates Inflammation by Activating the Nrf2-ARE Pathway.

Authors:  Samantha J Mascuch; Paul D Boudreau; Tristan M Carland; N Tessa Pierce; Joshua Olson; Mary E Hensler; Hyukjae Choi; Joseph Campanale; Amro Hamdoun; Victor Nizet; William H Gerwick; Teresa Gaasterland; Lena Gerwick
Journal:  J Nat Prod       Date:  2017-12-07       Impact factor: 4.050

Review 5.  The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Authors:  Prashant Deshmukh; Sruthi Unni; Gopinatha Krishnappa; Balasundaram Padmanabhan
Journal:  Biophys Rev       Date:  2016-12-06

6.  Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.

Authors:  Bridgid E Hast; Dennis Goldfarb; Kathleen M Mulvaney; Michael A Hast; Priscila F Siesser; Feng Yan; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

7.  Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.

Authors:  Phillip R Lazzara; Atul D Jain; Amanda C Maldonado; Benjamin Richardson; Kornelia J Skowron; Brian P David; Zamia Siddiqui; Kiira M Ratia; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

8.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

9.  Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Authors:  Youngtae Jeong; Ngoc T Hoang; Alexander Lovejoy; Henning Stehr; Aaron M Newman; Andrew J Gentles; William Kong; Diana Truong; Shanique Martin; Aadel Chaudhuri; Diane Heiser; Li Zhou; Carmen Say; Justin N Carter; Susan M Hiniker; Billy W Loo; Robert B West; Philip Beachy; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2016-09-23       Impact factor: 39.397

10.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.